Skip to main content
SpringerLink
Log in

Population Pharmacokinetic Analyses of Lithium: A Systematic Review

  • Systematic Review
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Abstract

Background and Objectives

Even though lithium has been used for the treatment of bipolar disorder for several decades, its toxicities are still being reported. The major limitation in the use of lithium is its narrow therapeutic window. Several methods have been proposed to predict lithium doses essential to attain therapeutic levels. One of the methods used to guide lithium therapy is population pharmacokinetic approach which accounts for inter- and intra-individual variability in predicting lithium doses. Several population pharmacokinetic studies of lithium have been conducted. The objective of this review is to provide information on population pharmacokinetics of lithium focusing on nonlinear mixed effect modeling approach and to summarize significant factors affecting lithium pharmacokinetics.

Methods

A literature search was conducted from PubMed database from inception to December, 2016. Studies conducted in humans, using lithium as a study drug, providing population pharmacokinetic analyses of lithium by means of nonlinear mixed effect modeling, were included in this review.

Results

Twenty-four articles were identified from the database. Seventeen articles were excluded based on the inclusion and exclusion criteria. A total of seven articles were included in this review. Of these, only one study reported a combined population pharmacokinetic–pharmacodynamic model of lithium. Lithium pharmacokinetics were explained using both one- and two-compartment models. The significant predictors of lithium clearance identified in most studies were renal function and body size. One study reported a significant effect of age on lithium clearance. The typical values of lithium clearance ranged from 0.41 to 9.39 L/h. The magnitude of inter-individual variability on lithium clearance ranged from 12.7 to 25.1%. Only two studies evaluated the models using external data sets.

Conclusions

Model methodologies in each study are summarized and discussed in this review. For future perspective, a population pharmacokinetic–pharmacodynamic study of lithium is recommended. Moreover, external validation of previously published models should be performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Association AP. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 Suppl):1–50.

    Google Scholar 

  2. Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach. Part II: clinical pharmacology and therapeutic monitoring. CNS Drugs. 2009;23(4):331–49.

    Article  CAS  PubMed  Google Scholar 

  3. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging. 2000;16(3):165–77.

    Article  CAS  PubMed  Google Scholar 

  4. Ghibellini G, Carson SW. Lithium. In: Murphy JE, editor. Clinical pharmacokinetics. Besthesda: ASHP; 2011. p. 243–62.

    Google Scholar 

  5. Bauer LA. Applied clinical pharmacokinetics. 3rd ed. New York: McGraw-Hill; 2014.

    Google Scholar 

  6. Mohandas E, Rajmohan V. Lithium use in special populations. Indian J Psychiatry. 2007;49(3):211–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Eyer F, Pfab R, Felgenhauer N, Lutz J, Heemann U, Steimer W, et al. Lithium poisoning: pharmacokinetics and clearance during different therapeutic measures. J Clin Psychopharmacol. 2006;26(3):325–30.

    Article  CAS  PubMed  Google Scholar 

  8. Carter L, Zolezzi M, Lewczyk A. An updated review of the optimal lithium dosage regimen for renal protection. Can J Psychiatry. 2013;58(10):595–600.

    Article  PubMed  Google Scholar 

  9. Huang HC, Chang YL, Lan TH, Chiu HJ, Liu WM, Lee T. Prediction of optimal lithium doses for Taiwanese psychiatric patients. J Clin Pharm Ther. 2008;33(2):115–21.

    Article  CAS  PubMed  Google Scholar 

  10. Zetin M, Garber D, Cramer M. A simple mathematical model for predicting lithium dose requirement. J Clin Psychiatry. 1983;44(4):144–5.

    CAS  PubMed  Google Scholar 

  11. Stip E, Dufresne J, Boulerice B, Elie R. Accuracy of the Pepin method to determine appropriate lithium dosages in healthy volunteers. J Psychiatry Neurosci. 2001;26(4):330.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Terao T, Oga T, Nozaki S, Ota A, Otsubo Y, Yamamoto S, et al. A further prospective evaluation of an equation to predict daily lithium dose. J Clin Psychiatry. 1995;56(5):193–5.

    CAS  PubMed  Google Scholar 

  13. Browne J, Patel R, Huffman C, Hussey B. Comparison of pharmacokinetic procedures for dosing lithium based on analysis of prediction error. Drug Intell Clin Pharm. 1988;22(3):227–31.

    Article  CAS  PubMed  Google Scholar 

  14. Findling RL, Landersdorfer CB, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, et al. First-dose pharmacokinetics of lithium carbonate in children and adolescents. J Clin Psychopharmacol. 2010;30(4):404–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Landersdorfer CB, Findling RL, Frazier JA, Kafantaris V, Kirkpatrick CM. Lithium in paediatric patients with bipolar disorder: implications for selection of dosage regimens via population pharmacokinetics/pharmacodynamics. Clin Pharmacokinet. 2017;56(1):77–90.

    Article  CAS  PubMed  Google Scholar 

  16. ElDesoky ES, Kumar V, Alorainy MS, Hamdi MM, Derendorf H. Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach. Int J Clin Pharmacol Ther. 2008;46(12):617–26.

    Article  CAS  PubMed  Google Scholar 

  17. Perez-Castello I, Mangas-Sanjuan V, Gonzalez-Garcia I, Gonzalez-Alvarez I, Bermejo M, Marco-Garbayo JL, et al. Population pharmacokinetic model of lithium and drug compliance assessment. Eur Neuropsychopharmacol. 2016;26(12):1868–76.

    Article  CAS  PubMed  Google Scholar 

  18. Yu W, Sun X, Li Y, Li M, Wang K, Li H. Population pharmacokinetics of lithium carbonate in young male healthy Chinese volunteers. Pharmacopsychiatry. 2016;49(5):177–81.

    Article  CAS  PubMed  Google Scholar 

  19. Yukawa E, Nomiyama N, Higuchi S, Aoyama T. Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens. Ther Drug Monit. 1993;15(2):75–82.

    Article  CAS  PubMed  Google Scholar 

  20. Jermain D, Crismon M, Martin E 3rd. Population pharmacokinetics of lithium. Clin Pharm. 1991;10(5):376–81.

    CAS  PubMed  Google Scholar 

  21. Türck D, Heinzel G, Luik G. Steady-state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam. Br J Clin Pharmacol. 2000;50(3):197–204.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ku J, Wu Z, Fang Y, Pei Y. Clinical study on the pharmacokinetics of lithium carbonate. Int J Clin Pharmacol Ther. 1987;25(12):648–50.

    CAS  Google Scholar 

  23. Lehmann W, Kanarkowski R, Matkowski K, Rybakowski J. Studies of lithium pharmacokinetics in patients with affective illness. Pol J Pharmacol Phar. 1987;40(1):47–54.

    Google Scholar 

  24. Mason R, McQueen E, Keary P, James NM. Pharmacokinetics of lithium: elimination half-time, renal clearance and apparent volume of distribution in schizophrenia. Clin Pharmacokinet. 1978;3(3):241–6.

    Article  CAS  PubMed  Google Scholar 

  25. Chen C, Veronese L, Yin Y. The effects of lamotrigine on the pharmacokinetics of lithium. Br J Clin Pharmacol. 2000;50(3):193–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Yang Y-Y, Yeh E, Chang SS, Deng H-C, Lee C-F. Maintenance lithium levels could be lowered: based on Taiwanese and Danish studies. J Formos Med Assoc. 1991;90(5):509–13.

    CAS  PubMed  Google Scholar 

  27. Hunter R. Steady-state pharmacokinetics of lithium carbonate in healthy subjects. Br J Clin Pharmacol. 1988;25(3):375–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Obach R, Borja J, Prunonosa J, Valles J, Torrent J, Izquierdo I, et al. Lack of correlation between lithium pharmacokinetic parameters obtained from plasma and saliva. Ther Drug Monit. 1988;10(3):265–8.

    Article  CAS  PubMed  Google Scholar 

  29. Winter ME. Basic clinical pharmacokinetics. 5th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2010.

    Google Scholar 

  30. Reiss RA, Haas CE, Karki SD, Gumbiner B, Welle SL, Carson SW. Lithium pharmacokinetics in the obese. Clin Pharmacol Ther. 1994;55(4):392–8.

    Article  CAS  PubMed  Google Scholar 

  31. Guilherme MC, Pereira DG, Galuppo MP, Mendes GD, Donato JL, De Nucci G. Bioequivalence of two lithium formulations in healthy volunteers. Arzneimittelforschung. 2006;56(07):524–8.

    CAS  PubMed  Google Scholar 

  32. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging. 2000;16(3):165–77.

    Article  CAS  PubMed  Google Scholar 

  33. Rej S, Beaulieu S, Segal M, Low NC, Mucsi I, Holcroft C, et al. Lithium dosing and serum concentrations across the age spectrum: from early adulthood to the tenth decade of life. Drugs Aging. 2014;31(12):911–6.

    Article  CAS  PubMed  Google Scholar 

  34. Mohandas E, Rajmohan V. Lithium use in special populations. Indian J Psychiatry. 2007;49(3):211.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Owen JS, Fiedler-Kelly J. Introduction to model evaluation. In: Owen JS, Fiedler-Kelly J, editors. Introduction to population pharmacokinetic/pharmacodynamic analysis with nonlinear mixed effects models. Wiley: Hoboken; 2014. p. 212–31.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacokinetic Research Unit, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, 65000, Thailand

    Janthima Methaneethorn

  2. Center of Excellence for Environmental Health and Toxicology, Naresuan University, Phitsanulok, Thailand

    Janthima Methaneethorn

Authors
  1. Janthima Methaneethorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janthima Methaneethorn.

Ethics declarations

Funding

No source of funding.

Conflict of interest

Janthima Methaneethorn declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Methaneethorn, J. Population Pharmacokinetic Analyses of Lithium: A Systematic Review. Eur J Drug Metab Pharmacokinet 43, 25–34 (2018). https://doi.org/10.1007/s13318-017-0421-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13318-017-0421-2

Search

Navigation